MLYS logo

Mineralys Therapeutics (MLYS) Working capital

annual working capital:

$190.71M-$47.92M(-20.08%)
December 31, 2024

Summary

  • As of today (June 17, 2025), MLYS annual working capital is $190.71 million, with the most recent change of -$47.92 million (-20.08%) on December 31, 2024.
  • During the last 3 years, MLYS annual working capital has risen by +$184.64 million (+3042.80%).
  • MLYS annual working capital is now -20.08% below its all-time high of $238.62 million, reached on December 31, 2023.

Performance

MLYS Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSbalance sheet metrics

quarterly working capital:

$341.12M+$150.41M(+78.87%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLYS quarterly working capital is $341.12 million, with the most recent change of +$150.41 million (+78.87%) on March 31, 2025.
  • Over the past year, MLYS quarterly working capital has increased by +$13.51 million (+4.12%).
  • MLYS quarterly working capital is now at all-time high.

Performance

MLYS quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

MLYS Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-20.1%+4.1%
3 y3 years+3042.8%-
5 y5 years+5372.5%+5521.6%

MLYS Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-20.1%+3042.8%at high+225.7%
5 y5-year-20.1%+5372.5%at high+5521.6%
alltimeall time-20.1%+5372.5%at high+5521.6%

MLYS Working capital History

DateAnnualQuarterly
Mar 2025
-
$341.12M(+78.9%)
Dec 2024
$190.71M(-20.1%)
$190.71M(-19.3%)
Sep 2024
-
$236.41M(-18.4%)
Jun 2024
-
$289.60M(-11.6%)
Mar 2024
-
$327.62M(+37.3%)
Dec 2023
$238.62M
$238.62M(-5.2%)
Sep 2023
-
$251.83M(-4.3%)
DateAnnualQuarterly
Jun 2023
-
$263.28M(-0.5%)
Mar 2023
-
$264.71M(+152.7%)
Dec 2022
$104.74M(+1626.2%)
$104.74M(-8.7%)
Sep 2022
-
$114.67M(+1789.7%)
Dec 2021
$6.07M(-267.8%)
-
Dec 2021
-
$6.07M
Dec 2020
-$3.62M
-

FAQ

  • What is Mineralys Therapeutics annual working capital?
  • What is the all time high annual working capital for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual working capital year-on-year change?
  • What is Mineralys Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly working capital year-on-year change?

What is Mineralys Therapeutics annual working capital?

The current annual working capital of MLYS is $190.71M

What is the all time high annual working capital for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual working capital is $238.62M

What is Mineralys Therapeutics annual working capital year-on-year change?

Over the past year, MLYS annual working capital has changed by -$47.92M (-20.08%)

What is Mineralys Therapeutics quarterly working capital?

The current quarterly working capital of MLYS is $341.12M

What is the all time high quarterly working capital for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly working capital is $341.12M

What is Mineralys Therapeutics quarterly working capital year-on-year change?

Over the past year, MLYS quarterly working capital has changed by +$13.51M (+4.12%)
On this page